Skip to main content
Equibles

Capital World Investors

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1422849 LOS ANGELES, CA
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$22,987,547
+$6,197,114 QoQ
Shares Held
551,657
+2.8% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 159 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Capital World Investors holds $27,435,334,973 across 33 Biotechnology names. RAPP ranks #27 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 26,115,014 $12,972,110,904
2 ALNY
Alnylam Pharmaceuticals, Inc.
 11,144,846 $3,354,932,991
3 ARGX
Argenx SE
 2,199,770 $2,040,880,612
4 IONS
Ionis Pharmaceuticals Inc
 21,669,226 $1,718,152,929
5 MRNA
Moderna, Inc.
 22,276,996 $1,560,058,029
6 RVMD
Revolution Medicines, Inc.
 4,008,244 $750,663,936
7 JAZZ
Jazz Pharmaceuticals plc
 2,697,610 $650,043,081
8 ONC
BeOne Medicines Ltd.
 2,249,582 $641,063,382

All Filings in RAPP

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,987,547 551,657
2026-03-31 $16,790,433 536,607